INTECH Investment Management’s Teva Pharmaceuticals TEVA Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $5.87M | Buy |
350,399
+1,059
| +0.3% | +$17.7K | 0.06% | 308 |
|
|
2025
Q1 | $5.37M | Buy |
349,340
+106,108
| +44% | +$1.63M | 0.06% | 303 |
|
|
2024
Q4 | $5.36M | Buy |
243,232
+218,850
| +898% | +$4.82M | 0.05% | 309 |
|
|
2024
Q3 | $439K | Buy |
+24,382
| New | +$439K | ﹤0.01% | 1301 |
|
|
2023
Q4 | – | Sell |
-15,239
| Closed | -$155K | – | 749 |
|
|
2023
Q3 | $155K | Sell |
15,239
-2,065
| -12% | -$21.1K | ﹤0.01% | 701 |
|
|
2023
Q2 | $130K | Sell |
17,304
-82,352
| -83% | -$620K | ﹤0.01% | 702 |
|
|
2023
Q1 | $882K | Sell |
99,656
-10,127
| -9% | -$89.6K | 0.01% | 538 |
|
|
2022
Q4 | $1M | Hold |
109,783
| – | – | 0.01% | 522 |
|
|
2022
Q3 | $886K | Sell |
109,783
-5,018
| -4% | -$40.5K | 0.01% | 522 |
|
|
2022
Q2 | $863K | Buy |
+114,801
| New | +$863K | 0.01% | 543 |
|